Hi-Tech Bio Laboratories Profile
Key Indicators
- Company Age 23 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -303.96%
(FY 2022)
- Ebitda -303.96%
(FY 2022)
- Net Worth -90.78%
(FY 2022)
- Total Assets -99.52%
(FY 2022)
About Hi-Tech Bio Laboratories
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Shilpa Wagh and Raghavendra Gaikaiwari serve as directors at the Company.
- CIN/LLPIN
U73100PN2001NPL016310
- Company No.
016310
- Company Classification
Private Not For Profit Company
- Incorporation Date
10 Jul 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hi-Tech Bio Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilpa Wagh  | Director | 04-Aug-2023 | Current |
| Raghavendra Gaikaiwari | Director | 10-Jul-2006 | Current |
Financial Performance of Hi-Tech Bio Laboratories.
Hi-Tech Bio Laboratories, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 303.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 90.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hi-Tech Bio Laboratories?
Unlock access to Hi-Tech Bio Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hi Tech Biosciences India Private LimitedActive 17 years 8 monthsShilpa Wagh and Raghavendra Gaikaiwari are mutual person
Hi Tech Biosynth Private LimitedActive 8 years 10 monthsShilpa Wagh and Raghavendra Gaikaiwari are mutual person
- Sci - Molecules India Private LimitedActive 23 years 9 months
Shilpa Wagh and Raghavendra Gaikaiwari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hi-Tech Bio Laboratories?
Unlock and access historical data on people associated with Hi-Tech Bio Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hi-Tech Bio Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hi-Tech Bio Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
